NASDAQ: CNTA
Centessa Pharmaceuticals PLC Stock Ownership - Who owns Centessa Pharmaceuticals?

Insider buying vs selling

Have Centessa Pharmaceuticals PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Tia L. BushChief Technology Quality Ofc2025-11-1740,000$28.00
$1.12MSell
Iqbal J. HussainGeneral Counsel2025-11-176,000$5.84
$35.04kBuy
Tia L. BushChief Technology Quality Ofc2025-11-1740,000$9.42
$376.80kBuy
Iqbal J. HussainGeneral Counsel2025-11-176,000$27.64
$165.83kSell
Tia L. BushChief Technology Quality Ofc2025-11-1240,000$26.00
$1.04MSell
Tia L. BushChief Technology Quality Ofc2025-11-1240,000$9.42
$376.80kBuy
Mario Alberto AccardiPresident Orexin Program2025-11-01593$24.90
$14.77kSell
Mario Alberto AccardiPresident Orexin Program2025-10-275,000$8.01
$40.05kBuy
Mario Alberto AccardiPresident Orexin Program2025-10-278,000$25.00
$200.00kSell
Iqbal J. HussainGeneral Counsel2025-10-156,000$22.41
$134.44kSell

1 of 11

CNTA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CNTA insiders and whales buy or sell their stock.

CNTA Shareholders

What type of owners hold Centessa Pharmaceuticals PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Medicxi Ventures Management Jersey Ltd14.85%19,963,157$590.11MInstitution
Avoro Capital Advisors LLC8.04%10,808,080$319.49MInstitution
Adage Capital Partners GP LLC7.46%10,035,000$296.63MInstitution
Index Venture Life Associates VI Ltd7.41%9,961,789$294.47MInstitution
Gap Bermuda Ltd7.20%9,681,818$286.19MInsider
General Atlantic LP7.20%9,681,818$286.19MInstitution
Fmr LLC4.67%6,277,243$185.56MInstitution
Janus Henderson Group PLC4.02%5,408,199$159.87MInstitution
Price T Rowe Associates Inc3.57%4,804,056$142.01MInstitution
Farallon Capital Management LLC3.22%4,331,318$128.03MInstitution

1 of 3

CNTA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CNTA90.29%9.71%Net SellingNet Selling
ACLX51.42%48.58%Net SellingNet Selling
IMVT48.27%51.73%Net BuyingNet Selling
NAMS74.81%25.19%Net SellingNet Buying
ARQT76.71%23.29%Net SellingNet Selling

Centessa Pharmaceuticals Stock Ownership FAQ

Who owns Centessa Pharmaceuticals?

Centessa Pharmaceuticals (NASDAQ: CNTA) is owned by 95.45% institutional shareholders, 10.26% Centessa Pharmaceuticals insiders, and 0.00% retail investors. Gap Bermuda Ltd is the largest individual Centessa Pharmaceuticals shareholder, owning 9.68M shares representing 7.20% of the company. Gap Bermuda Ltd's Centessa Pharmaceuticals shares are currently valued at $289.58M.

If you're new to stock investing, here's how to buy Centessa Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.